Storage Condition
Store at freezer (-20°C) for long term storage
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Paricalcitol-d6 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Paricalcitol-d6 usage and description
Paricalcitol D6 is a deuterated form of Paricalcitol, which is a synthetic Vitamin D analog. It is primarily used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. The drug works by regulating the levels of parathyroid hormone (PTH) in the body, which is responsible for the maintenance of calcium and phosphate homeostasis. Patients with chronic kidney disease have impaired kidney function, which leads to an increase in PTH levels, resulting in mineral and bone disorders. Paricalcitol D6 helps reduce PTH levels, thereby improving bone health and reducing the risk of fractures.
The chemical formula of Paricalcitol D6 is C27H33D6NO3, and its molecular weight is 427.6 g/mol. The drug is administered orally, either as a capsule or as a liquid solution. It is metabolized in the liver and excreted through the feces. Paricalcitol D6 is a lipophilic compound, and its absorption is enhanced by the presence of food.
Paricalcitol D6 is a safe and effective drug for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. However, like all drugs, it may have some side effects, including nausea, vomiting, headache, and dizziness. It is important to consult a healthcare provider before taking Paricalcitol D6 to ensure that it is safe and appropriate for individual use.
